Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atlanta Neuroscience Institute (ANI) is an independent, non-profit neurological practice and clinical research center based in Atlanta, Georgia. Originally founded in 2001 as the Multiple Sclerosis Center of Atlanta, the institute rebranded in 2022 to reflect its expanded care model covering a broader range of chronic neurological conditions, including multiple sclerosis, Parkinson's disease, epilepsy, and Alzheimer's disease. ANI offers a holistic care model that integrates direct clinical treatment, advanced neuroimaging, in-house infusion therapies, case management, and pharmacy support under one roof. Additionally, the institute actively participates in and conducts clinical trials, giving patients access to cutting-edge neurological therapies and contributing to global scientific advancements in brain health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atlanta Neuroscience Institute.